Note: This is NOT an IPO. This is a NASDAQ  Direct Listing. Digital Offering LLC is the financial advisor. The registered shareholders have filed to sell up 6.11 million shares. For illustration purposes, the price is $7.00 – the highest price that the company’s stock has sold for recently, according to the prospectus. We are […]

(Incorporated in British Columbia) Note: This is NOT an IPO. This is a NASDAQ Direct Listing. Selling stockholders of Roze AI have filed to sell up  to 18.14 million shares of common stock, including 13.88 million outstanding shares and 4.26 million common shares issuable upon exercise of warrants. Roze AI expects its common stock to […]

Note: This is NOT an IPO. This is a NASDAQ Uplisting – a public offering – of Interpace Biosciences’ common stock on the NASDAQ – moving it up from the OTC Market where it’s currently listed. The last reported sale price of our common stock on the OTCID tier operated by OTC Markets Group Inc. […]

(Incorporated in Delaware) We develop and manufacture medical devices for tissue repair and other healing situations. Our two major products are RegenKit, a PRP preparation kit, and Cellular Matrix, a PRP-HA combination for knee osteoarthritis. Most of our products have received the CE mark in Europe Our wound gel is covered by Medicare. Many of […]

Note: TCGX Acquisition Corp. II is offering only stock in its SPAC IPO. A typical SPAC IPO consists of units, with each unit made up of a share of stock plus a warrant or a right, or a fraction of a warrant or a right – or both – with the right to receive a […]

(Incorporated in Bermuda) Our mission is to be the leading originator and allocator of (re)insurance risk, combining high-conviction underwriting and portfolio solutions powered by technology, data and AI, to create enduring partnerships and deliver better outcomes for (re)insureds, brokers, and Capacity Providers. Who We Are TFP is the world’s largest independent MGA. We are a […]

(Incorporated in Delaware) We are a clinical biotech company focused on developing RNA interference (RNAi) therapeutics to silence disease-relevant proteins. We are focused on thromboembolic diseases, Type 1 Stargardt disease, and anemia associated with chronic disease. Led by pioneers and experts in the field of RNAi, we have made rapid progress since founding our company […]

(Incorporated in the Cayman Islands) We are a newly established blank check company. We are affiliated with Bluerock, an alternative asset manager. We intend to focus on businesses in sectors such as Web3 (decentralized platforms and digital assets, and data-intensive FinTech infrastructure) that have one or more of the following attributes: robust growth prospectus, recurring […]

Note: This is a stock-only SPAC IPO – an exception to the usual structure. A SPAC IPO typically consists of a share of common stock and a warrant or a right to acquire a share (or a fraction of a share) of stock upon the consummation of the SPAC’s initial business combination. We are a […]

(Incorporated in Delaware) Our vision is to unlock the full potential of quantum computing by enabling scalable, commercially viable quantum systems. We work across the quantum computing ecosystem with hardware developers, integrators, advanced computing partners, manufacturing collaborators and government-supported programs. We believe the path to scale will mirror classical computing, with enabling technologies spanning foundry, […]